Detrimental	O
Effect	O
of	O
Fungal	B:C0016832
60	O
-	O
kDa	O
Heat	O
Shock	I:C0018850
Protein	I:C0018850
on	O
Experimental	O
Paracoccidioides	O
brasiliensis	I:C0030409
Infection	I:C0030409
.	O

Detrimental	O
Effect	O
of	O
Fungal	O
60	O
-	O
kDa	O
Heat	B:C0018850
Shock	I:C0018850
Protein	I:C0018850
on	O
Experimental	O
Paracoccidioides	O
brasiliensis	I:C0030409
Infection	I:C0030409
.	O

Detrimental	O
Effect	O
of	O
Fungal	O
60	O
-	O
kDa	O
Heat	O
Shock	I:C0018850
Protein	I:C0018850
on	O
Experimental	O
Paracoccidioides	B:C0030409
brasiliensis	I:C0030409
Infection	I:C0030409
.	O

The	O
genus	B:C1708235
Paracoccidioides	O
comprises	O
species	O
of	O
dimorphic	O
fungi	I:C1562222
that	O
cause	O
paracoccidioidomycosis	O
(	O
paracoccidioidomycosis	O
)	O
,	O
a	O
systemic	O
disease	I:C0442893
prevalent	O
in	O
Latin	O
America	I:C0023122
.	O

The	O
genus	O
Paracoccidioides	B:C0030407
comprises	O
species	O
of	O
dimorphic	O
fungi	I:C1562222
that	O
cause	O
paracoccidioidomycosis	O
(	O
paracoccidioidomycosis	O
)	O
,	O
a	O
systemic	O
disease	I:C0442893
prevalent	O
in	O
Latin	O
America	I:C0023122
.	O

The	O
genus	O
Paracoccidioides	O
comprises	O
species	B:C1705920
of	O
dimorphic	O
fungi	I:C1562222
that	O
cause	O
paracoccidioidomycosis	O
(	O
paracoccidioidomycosis	O
)	O
,	O
a	O
systemic	O
disease	I:C0442893
prevalent	O
in	O
Latin	O
America	I:C0023122
.	O

The	O
genus	O
Paracoccidioides	O
comprises	O
species	O
of	O
dimorphic	B:C1562222
fungi	I:C1562222
that	O
cause	O
paracoccidioidomycosis	O
(	O
paracoccidioidomycosis	O
)	O
,	O
a	O
systemic	O
disease	I:C0442893
prevalent	O
in	O
Latin	O
America	I:C0023122
.	O

The	O
genus	O
Paracoccidioides	O
comprises	O
species	O
of	O
dimorphic	O
fungi	I:C1562222
that	O
cause	O
paracoccidioidomycosis	B:C0030409
(	O
paracoccidioidomycosis	O
)	O
,	O
a	O
systemic	O
disease	I:C0442893
prevalent	O
in	O
Latin	O
America	I:C0023122
.	O

The	O
genus	O
Paracoccidioides	O
comprises	O
species	O
of	O
dimorphic	O
fungi	I:C1562222
that	O
cause	O
paracoccidioidomycosis	O
(	O
paracoccidioidomycosis	B:C0030409
)	O
,	O
a	O
systemic	O
disease	I:C0442893
prevalent	O
in	O
Latin	O
America	I:C0023122
.	O

The	O
genus	O
Paracoccidioides	O
comprises	O
species	O
of	O
dimorphic	O
fungi	I:C1562222
that	O
cause	O
paracoccidioidomycosis	O
(	O
paracoccidioidomycosis	O
)	O
,	O
a	O
systemic	B:C0442893
disease	I:C0442893
prevalent	O
in	O
Latin	O
America	I:C0023122
.	O

The	O
genus	O
Paracoccidioides	O
comprises	O
species	O
of	O
dimorphic	O
fungi	I:C1562222
that	O
cause	O
paracoccidioidomycosis	O
(	O
paracoccidioidomycosis	O
)	O
,	O
a	O
systemic	O
disease	I:C0442893
prevalent	O
in	O
Latin	B:C0023122
America	I:C0023122
.	O

Here	O
,	O
we	O
investigated	O
whether	O
administration	O
of	O
native	B:C0018850
60	I:C0018850
-	I:C0018850
kDa	I:C0018850
heat	I:C0018850
shock	I:C0018850
protein	I:C0018850
of	O
P.	O
brasiliensis	I:C1622980
(	O
nPbHsp60	O
)	O
or	O
its	O
recombinant	O
counterpart	I:C0034861
(	O
rPbHsp60	O
)	O
affected	O
the	O
course	O
of	O
experimental	O
paracoccidioidomycosis	O
.	O

Here	O
,	O
we	O
investigated	O
whether	O
administration	O
of	O
native	O
60	I:C0018850
-	I:C0018850
kDa	I:C0018850
heat	I:C0018850
shock	I:C0018850
protein	I:C0018850
of	O
P.	B:C1622980
brasiliensis	I:C1622980
(	O
nPbHsp60	O
)	O
or	O
its	O
recombinant	O
counterpart	I:C0034861
(	O
rPbHsp60	O
)	O
affected	O
the	O
course	O
of	O
experimental	O
paracoccidioidomycosis	O
.	O

Here	O
,	O
we	O
investigated	O
whether	O
administration	O
of	O
native	O
60	I:C0018850
-	I:C0018850
kDa	I:C0018850
heat	I:C0018850
shock	I:C0018850
protein	I:C0018850
of	O
P.	O
brasiliensis	I:C1622980
(	O
nPbHsp60	B:C0018850
)	O
or	O
its	O
recombinant	O
counterpart	I:C0034861
(	O
rPbHsp60	O
)	O
affected	O
the	O
course	O
of	O
experimental	O
paracoccidioidomycosis	O
.	O

Here	O
,	O
we	O
investigated	O
whether	O
administration	O
of	O
native	O
60	I:C0018850
-	I:C0018850
kDa	I:C0018850
heat	I:C0018850
shock	I:C0018850
protein	I:C0018850
of	O
P.	O
brasiliensis	I:C1622980
(	O
nPbHsp60	O
)	O
or	O
its	O
recombinant	B:C0034861
counterpart	I:C0034861
(	O
rPbHsp60	O
)	O
affected	O
the	O
course	O
of	O
experimental	O
paracoccidioidomycosis	O
.	O

Here	O
,	O
we	O
investigated	O
whether	O
administration	O
of	O
native	O
60	I:C0018850
-	I:C0018850
kDa	I:C0018850
heat	I:C0018850
shock	I:C0018850
protein	I:C0018850
of	O
P.	O
brasiliensis	I:C1622980
(	O
nPbHsp60	O
)	O
or	O
its	O
recombinant	O
counterpart	I:C0034861
(	O
rPbHsp60	B:C0034861
)	O
affected	O
the	O
course	O
of	O
experimental	O
paracoccidioidomycosis	O
.	O

Here	O
,	O
we	O
investigated	O
whether	O
administration	O
of	O
native	O
60	I:C0018850
-	I:C0018850
kDa	I:C0018850
heat	I:C0018850
shock	I:C0018850
protein	I:C0018850
of	O
P.	O
brasiliensis	I:C1622980
(	O
nPbHsp60	O
)	O
or	O
its	O
recombinant	O
counterpart	I:C0034861
(	O
rPbHsp60	O
)	O
affected	O
the	O
course	O
of	O
experimental	O
paracoccidioidomycosis	B:C0030409
.	O

Mice	B:C0025929
were	O
subcutaneously	O
injected	O
with	O
nPbHsp60	O
or	O
rPbHsp60	O
emulsified	O
in	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
(	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
)	O
at	O
three	O
weeks	O
after	O
intravenous	O
injection	O
of	O
P.	O
brasiliensis	I:C1622980
yeasts	I:C1622980
.	O

Mice	O
were	O
subcutaneously	O
injected	O
with	O
nPbHsp60	B:C0018850
or	O
rPbHsp60	O
emulsified	O
in	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
(	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
)	O
at	O
three	O
weeks	O
after	O
intravenous	O
injection	O
of	O
P.	O
brasiliensis	I:C1622980
yeasts	I:C1622980
.	O

Mice	O
were	O
subcutaneously	O
injected	O
with	O
nPbHsp60	O
or	O
rPbHsp60	B:C0034861
emulsified	O
in	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
(	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
)	O
at	O
three	O
weeks	O
after	O
intravenous	O
injection	O
of	O
P.	O
brasiliensis	I:C1622980
yeasts	I:C1622980
.	O

Mice	O
were	O
subcutaneously	O
injected	O
with	O
nPbHsp60	O
or	O
rPbHsp60	O
emulsified	B:C0221105
in	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
(	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
)	O
at	O
three	O
weeks	O
after	O
intravenous	O
injection	O
of	O
P.	O
brasiliensis	I:C1622980
yeasts	I:C1622980
.	O

Mice	O
were	O
subcutaneously	O
injected	O
with	O
nPbHsp60	O
or	O
rPbHsp60	O
emulsified	O
in	O
complete	B:C0016712
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
(	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
)	O
at	O
three	O
weeks	O
after	O
intravenous	O
injection	O
of	O
P.	O
brasiliensis	I:C1622980
yeasts	I:C1622980
.	O

Mice	O
were	O
subcutaneously	O
injected	O
with	O
nPbHsp60	O
or	O
rPbHsp60	O
emulsified	O
in	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
(	O
complete	B:C0016712
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
)	O
at	O
three	O
weeks	O
after	O
intravenous	O
injection	O
of	O
P.	O
brasiliensis	I:C1622980
yeasts	I:C1622980
.	O

Mice	O
were	O
subcutaneously	O
injected	O
with	O
nPbHsp60	O
or	O
rPbHsp60	O
emulsified	O
in	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
(	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
)	O
at	O
three	O
weeks	O
after	O
intravenous	O
injection	O
of	O
P.	B:C1622980
brasiliensis	I:C1622980
yeasts	I:C1622980
.	O

Infected	B:C0439663
control	O
mice	O
were	O
injected	O
with	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
or	O
isotonic	O
saline	O
solution	O
alone	O
.	O

Infected	O
control	O
mice	B:C0025929
were	O
injected	O
with	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
or	O
isotonic	O
saline	O
solution	O
alone	O
.	O

Infected	O
control	O
mice	O
were	O
injected	O
with	O
complete	B:C0016712
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
or	O
isotonic	O
saline	O
solution	O
alone	O
.	O

Thirty	O
days	O
after	O
the	O
nPbHsp60	B:C0018850
or	O
rPbHsp60	O
administration	O
,	O
mice	O
showed	O
remarkably	O
increased	O
fungal	O
load	O
,	O
tissue	O
inflammation	O
,	O
and	O
granulomas	O
in	I:C0235557
the	I:C0235557
lungs	I:C0235557
,	O
liver	O
,	O
and	O
spleen	O
compared	O
with	O
control	O
mice	O
.	O

Thirty	O
days	O
after	O
the	O
nPbHsp60	O
or	O
rPbHsp60	B:C0018850
administration	O
,	O
mice	O
showed	O
remarkably	O
increased	O
fungal	O
load	O
,	O
tissue	O
inflammation	O
,	O
and	O
granulomas	O
in	I:C0235557
the	I:C0235557
lungs	I:C0235557
,	O
liver	O
,	O
and	O
spleen	O
compared	O
with	O
control	O
mice	O
.	O

Thirty	O
days	O
after	O
the	O
nPbHsp60	O
or	O
rPbHsp60	O
administration	O
,	O
mice	B:C0025929
showed	O
remarkably	O
increased	O
fungal	O
load	O
,	O
tissue	O
inflammation	O
,	O
and	O
granulomas	O
in	I:C0235557
the	I:C0235557
lungs	I:C0235557
,	O
liver	O
,	O
and	O
spleen	O
compared	O
with	O
control	O
mice	O
.	O

Thirty	O
days	O
after	O
the	O
nPbHsp60	O
or	O
rPbHsp60	O
administration	O
,	O
mice	O
showed	O
remarkably	O
increased	O
fungal	O
load	O
,	O
tissue	B:C0040300
inflammation	O
,	O
and	O
granulomas	O
in	I:C0235557
the	I:C0235557
lungs	I:C0235557
,	O
liver	O
,	O
and	O
spleen	O
compared	O
with	O
control	O
mice	O
.	O

Thirty	O
days	O
after	O
the	O
nPbHsp60	O
or	O
rPbHsp60	O
administration	O
,	O
mice	O
showed	O
remarkably	O
increased	O
fungal	O
load	O
,	O
tissue	O
inflammation	B:C0021368
,	O
and	O
granulomas	O
in	I:C0235557
the	I:C0235557
lungs	I:C0235557
,	O
liver	O
,	O
and	O
spleen	O
compared	O
with	O
control	O
mice	O
.	O

Thirty	O
days	O
after	O
the	O
nPbHsp60	O
or	O
rPbHsp60	O
administration	O
,	O
mice	O
showed	O
remarkably	O
increased	O
fungal	O
load	O
,	O
tissue	O
inflammation	O
,	O
and	O
granulomas	B:C0235557
in	I:C0235557
the	I:C0235557
lungs	I:C0235557
,	O
liver	O
,	O
and	O
spleen	O
compared	O
with	O
control	O
mice	O
.	O

Thirty	O
days	O
after	O
the	O
nPbHsp60	O
or	O
rPbHsp60	O
administration	O
,	O
mice	O
showed	O
remarkably	O
increased	O
fungal	O
load	O
,	O
tissue	O
inflammation	O
,	O
and	O
granulomas	O
in	I:C0235557
the	I:C0235557
lungs	I:C0235557
,	O
liver	B:C0745754
,	O
and	O
spleen	O
compared	O
with	O
control	O
mice	O
.	O

Thirty	O
days	O
after	O
the	O
nPbHsp60	O
or	O
rPbHsp60	O
administration	O
,	O
mice	O
showed	O
remarkably	O
increased	O
fungal	O
load	O
,	O
tissue	O
inflammation	O
,	O
and	O
granulomas	O
in	I:C0235557
the	I:C0235557
lungs	I:C0235557
,	O
liver	O
,	O
and	O
spleen	B:C1535984
compared	O
with	O
control	O
mice	O
.	O

Thirty	O
days	O
after	O
the	O
nPbHsp60	O
or	O
rPbHsp60	O
administration	O
,	O
mice	O
showed	O
remarkably	O
increased	O
fungal	O
load	O
,	O
tissue	O
inflammation	O
,	O
and	O
granulomas	O
in	I:C0235557
the	I:C0235557
lungs	I:C0235557
,	O
liver	O
,	O
and	O
spleen	O
compared	O
with	O
control	O
mice	B:C0025929
.	O

Further	O
,	O
rPbHsp60	B:C0034861
treatment	O
(	O
i	O
)	O
decreased	O
the	O
known	O
protective	O
effect	O
of	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
against	O
paracoccidioidomycosis	O
and	O
(	O
ii	O
)	O
increased	O
the	O
concentrations	O
of	O
IL	O
-	I:C0384648
17	I:C0384648
,	O
TNF-α	O
,	O
IL	O
-	I:C0123759
12	I:C0123759
,	O
IFN	O
-γ	I:C0021745
,	O
IL	O
-	I:C0021758
4	I:C0021758
,	O
IL	O
-	I:C0085295
10	I:C0085295
,	O
and	O
TGF	O
-β	I:C0076930
in	O
the	O
lungs	O
.	O

Further	O
,	O
rPbHsp60	O
treatment	O
(	O
i	O
)	O
decreased	O
the	O
known	O
protective	O
effect	O
of	O
complete	B:C0016712
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
against	O
paracoccidioidomycosis	O
and	O
(	O
ii	O
)	O
increased	O
the	O
concentrations	O
of	O
IL	O
-	I:C0384648
17	I:C0384648
,	O
TNF-α	O
,	O
IL	O
-	I:C0123759
12	I:C0123759
,	O
IFN	O
-γ	I:C0021745
,	O
IL	O
-	I:C0021758
4	I:C0021758
,	O
IL	O
-	I:C0085295
10	I:C0085295
,	O
and	O
TGF	O
-β	I:C0076930
in	O
the	O
lungs	O
.	O

Further	O
,	O
rPbHsp60	O
treatment	O
(	O
i	O
)	O
decreased	O
the	O
known	O
protective	O
effect	O
of	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
against	O
paracoccidioidomycosis	B:C0030409
and	O
(	O
ii	O
)	O
increased	O
the	O
concentrations	O
of	O
IL	O
-	I:C0384648
17	I:C0384648
,	O
TNF-α	O
,	O
IL	O
-	I:C0123759
12	I:C0123759
,	O
IFN	O
-γ	I:C0021745
,	O
IL	O
-	I:C0021758
4	I:C0021758
,	O
IL	O
-	I:C0085295
10	I:C0085295
,	O
and	O
TGF	O
-β	I:C0076930
in	O
the	O
lungs	O
.	O

Further	O
,	O
rPbHsp60	O
treatment	O
(	O
i	O
)	O
decreased	O
the	O
known	O
protective	O
effect	O
of	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
against	O
paracoccidioidomycosis	O
and	O
(	O
ii	O
)	O
increased	O
the	O
concentrations	O
of	O
IL	B:C0384648
-	I:C0384648
17	I:C0384648
,	O
TNF-α	O
,	O
IL	O
-	I:C0123759
12	I:C0123759
,	O
IFN	O
-γ	I:C0021745
,	O
IL	O
-	I:C0021758
4	I:C0021758
,	O
IL	O
-	I:C0085295
10	I:C0085295
,	O
and	O
TGF	O
-β	I:C0076930
in	O
the	O
lungs	O
.	O

Further	O
,	O
rPbHsp60	O
treatment	O
(	O
i	O
)	O
decreased	O
the	O
known	O
protective	O
effect	O
of	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
against	O
paracoccidioidomycosis	O
and	O
(	O
ii	O
)	O
increased	O
the	O
concentrations	O
of	O
IL	O
-	I:C0384648
17	I:C0384648
,	O
TNF-α	B:C1456820
,	O
IL	O
-	I:C0123759
12	I:C0123759
,	O
IFN	O
-γ	I:C0021745
,	O
IL	O
-	I:C0021758
4	I:C0021758
,	O
IL	O
-	I:C0085295
10	I:C0085295
,	O
and	O
TGF	O
-β	I:C0076930
in	O
the	O
lungs	O
.	O

Further	O
,	O
rPbHsp60	O
treatment	O
(	O
i	O
)	O
decreased	O
the	O
known	O
protective	O
effect	O
of	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
against	O
paracoccidioidomycosis	O
and	O
(	O
ii	O
)	O
increased	O
the	O
concentrations	O
of	O
IL	O
-	I:C0384648
17	I:C0384648
,	O
TNF-α	O
,	O
IL	B:C0123759
-	I:C0123759
12	I:C0123759
,	O
IFN	O
-γ	I:C0021745
,	O
IL	O
-	I:C0021758
4	I:C0021758
,	O
IL	O
-	I:C0085295
10	I:C0085295
,	O
and	O
TGF	O
-β	I:C0076930
in	O
the	O
lungs	O
.	O

Further	O
,	O
rPbHsp60	O
treatment	O
(	O
i	O
)	O
decreased	O
the	O
known	O
protective	O
effect	O
of	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
against	O
paracoccidioidomycosis	O
and	O
(	O
ii	O
)	O
increased	O
the	O
concentrations	O
of	O
IL	O
-	I:C0384648
17	I:C0384648
,	O
TNF-α	O
,	O
IL	O
-	I:C0123759
12	I:C0123759
,	O
IFN	B:C0021745
-γ	I:C0021745
,	O
IL	O
-	I:C0021758
4	I:C0021758
,	O
IL	O
-	I:C0085295
10	I:C0085295
,	O
and	O
TGF	O
-β	I:C0076930
in	O
the	O
lungs	O
.	O

Further	O
,	O
rPbHsp60	O
treatment	O
(	O
i	O
)	O
decreased	O
the	O
known	O
protective	O
effect	O
of	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
against	O
paracoccidioidomycosis	O
and	O
(	O
ii	O
)	O
increased	O
the	O
concentrations	O
of	O
IL	O
-	I:C0384648
17	I:C0384648
,	O
TNF-α	O
,	O
IL	O
-	I:C0123759
12	I:C0123759
,	O
IFN	O
-γ	I:C0021745
,	O
IL	B:C0021758
-	I:C0021758
4	I:C0021758
,	O
IL	O
-	I:C0085295
10	I:C0085295
,	O
and	O
TGF	O
-β	I:C0076930
in	O
the	O
lungs	O
.	O

Further	O
,	O
rPbHsp60	O
treatment	O
(	O
i	O
)	O
decreased	O
the	O
known	O
protective	O
effect	O
of	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
against	O
paracoccidioidomycosis	O
and	O
(	O
ii	O
)	O
increased	O
the	O
concentrations	O
of	O
IL	O
-	I:C0384648
17	I:C0384648
,	O
TNF-α	O
,	O
IL	O
-	I:C0123759
12	I:C0123759
,	O
IFN	O
-γ	I:C0021745
,	O
IL	O
-	I:C0021758
4	I:C0021758
,	O
IL	B:C0085295
-	I:C0085295
10	I:C0085295
,	O
and	O
TGF	O
-β	I:C0076930
in	O
the	O
lungs	O
.	O

Further	O
,	O
rPbHsp60	O
treatment	O
(	O
i	O
)	O
decreased	O
the	O
known	O
protective	O
effect	O
of	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
against	O
paracoccidioidomycosis	O
and	O
(	O
ii	O
)	O
increased	O
the	O
concentrations	O
of	O
IL	O
-	I:C0384648
17	I:C0384648
,	O
TNF-α	O
,	O
IL	O
-	I:C0123759
12	I:C0123759
,	O
IFN	O
-γ	I:C0021745
,	O
IL	O
-	I:C0021758
4	I:C0021758
,	O
IL	O
-	I:C0085295
10	I:C0085295
,	O
and	O
TGF	B:C0076930
-β	I:C0076930
in	O
the	O
lungs	O
.	O

Further	O
,	O
rPbHsp60	O
treatment	O
(	O
i	O
)	O
decreased	O
the	O
known	O
protective	O
effect	O
of	O
complete	O
's	I:C0016712
Freund	I:C0016712
Adjuvant	I:C0016712
against	O
paracoccidioidomycosis	O
and	O
(	O
ii	O
)	O
increased	O
the	O
concentrations	O
of	O
IL	O
-	I:C0384648
17	I:C0384648
,	O
TNF-α	O
,	O
IL	O
-	I:C0123759
12	I:C0123759
,	O
IFN	O
-γ	I:C0021745
,	O
IL	O
-	I:C0021758
4	I:C0021758
,	O
IL	O
-	I:C0085295
10	I:C0085295
,	O
and	O
TGF	O
-β	I:C0076930
in	O
the	O
lungs	B:C0024109
.	O

Together	O
,	O
our	O
results	O
indicated	O
that	O
PbHsp60	B:C0018850
induced	O
a	O
harmful	O
immune	O
response	I:C0301872
,	O
exacerbated	O
inflammation	O
,	O
and	O
promoted	O
fungal	O
dissemination	O
.	O

Together	O
,	O
our	O
results	O
indicated	O
that	O
PbHsp60	O
induced	O
a	O
harmful	O
immune	B:C0301872
response	I:C0301872
,	O
exacerbated	O
inflammation	O
,	O
and	O
promoted	O
fungal	O
dissemination	O
.	O

Together	O
,	O
our	O
results	O
indicated	O
that	O
PbHsp60	O
induced	O
a	O
harmful	O
immune	O
response	I:C0301872
,	O
exacerbated	O
inflammation	B:C0021368
,	O
and	O
promoted	O
fungal	O
dissemination	O
.	O

Together	O
,	O
our	O
results	O
indicated	O
that	O
PbHsp60	O
induced	O
a	O
harmful	O
immune	O
response	I:C0301872
,	O
exacerbated	O
inflammation	O
,	O
and	O
promoted	O
fungal	O
dissemination	B:C0205221
.	O

Therefore	O
,	O
we	O
propose	O
that	O
PbHsp60	B:C0018850
contributes	O
to	O
the	O
fungal	O
pathogenesis	O
.	O

Therefore	O
,	O
we	O
propose	O
that	O
PbHsp60	O
contributes	O
to	O
the	O
fungal	O
pathogenesis	B:C0699748
.	O

